Celldex Therapeutics Ownership | Who Owns Celldex Therapeutics?
Celldex Therapeutics Ownership Summary
Celldex Therapeutics is owned by 60.45% institutional investors, 0.30% insiders, and 39.25% retail investors. Wellington management group llp is the largest institutional shareholder, holding 13.54% of CLDX shares. Vanguard Health Care Inv is the top mutual fund, with 6.86% of its assets in Celldex Therapeutics shares.
CLDX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Celldex Therapeutics | 60.45% | 0.30% | 39.25% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Wellington management group llp | 8.98M | 13.54% | $226.82M |
| Blackrock funding, inc. /de | 5.48M | 8.27% | $138.50M |
| Blackrock | 4.69M | 7.97% | $173.61M |
| Kynam capital management, lp | 5.06M | 7.64% | $127.97M |
| Fmr | 4.86M | 7.33% | $122.75M |
| Vanguard group | 3.88M | 5.86% | $98.10M |
| Eventide asset management | 3.75M | 5.66% | $94.84M |
| Price t rowe associates inc /md/ | 3.56M | 5.37% | $89.89M |
| State street | 3.23M | 4.88% | $81.75M |
| Bellevue group | 3.07M | 4.63% | $77.62M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kynam capital management, lp | 5.06M | 7.56% | $127.97M |
| 5am venture management | 497.27K | 3.00% | $12.57M |
| Sphera funds management | 474.10K | 2.17% | $11.98M |
| Tsp capital management group | 223.34K | 1.92% | $5.64M |
| Eventide asset management | 3.75M | 1.73% | $94.84M |
| Eversept partners, lp | 719.84K | 1.61% | $18.19M |
| Novo | 1.00M | 1.53% | $25.27M |
| Bellevue group | 3.07M | 1.49% | $77.62M |
| Silverarc capital management | 264.56K | 1.46% | $6.69M |
| Deep track capital, lp | 1.54M | 1.45% | $38.92M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jefferies financial group | 2.39M | 0.36% | 2.37M |
| Kynam capital management, lp | 5.06M | 7.56% | 1.61M |
| Deep track capital, lp | 1.54M | 1.45% | 1.54M |
| Point72 asset management | 2.52M | 0.14% | 947.26K |
| State street | 3.23M | 0.00% | 749.80K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Commodore capital lp | - | - | -1.62M |
| Jennison associates | - | - | -1.32M |
| Fmr | 4.86M | 0.01% | -1.17M |
| Polar capital | 1.57M | 0.22% | -1.16M |
| Logos global management lp | - | - | -900.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Deep track capital, lp | 1.54M | 1.45% | 1.54M | $38.92M |
| Vestal point capital, lp | 305.00K | 0.46% | 305.00K | $7.71M |
| Tfg asset management gp | 192.00K | 1.20% | 192.00K | $4.85M |
| Cubist systematic strategies | 154.51K | 0.02% | 154.51K | $3.90M |
| Hudson bay capital management lp | 45.00K | 0.00% | 45.00K | $1.14M |
Sold Out
| Holder | Change |
|---|---|
| Assetmark | -1.00 |
| Umb bank, n.a. | -2.00 |
| Scarborough advisors | -6.00 |
| Nelson, van denburg & campbell wealth management group | -10.00 |
| Householder group estate & retirement specialist | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 122 | -38.69% | 40,075,962 | -44.20% | 60 | 0.52% | 68 | -28.42% | 29 | -47.27% |
| Sep 30, 2024 | 199 | 6.42% | 71,815,551 | 3.19% | 108 | 0.78% | 95 | -8.65% | 55 | 14.58% |
| Jun 30, 2024 | 187 | -8.33% | 69,597,419 | 0.41% | 118 | 0.85% | 104 | -18.75% | 48 | 11.63% |
| Mar 31, 2024 | 204 | 15.25% | 69,309,919 | 13.65% | 117 | 0.86% | 128 | 40.66% | 43 | -10.42% |
| Dec 31, 2023 | 177 | 12.03% | 60,984,745 | 20.59% | 117 | 1.02% | 91 | 15.19% | 48 | 14.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 4.55M | 6.86% | 7.20K |
| BB Biotech AG Ord | 3.07M | 4.63% | - |
| Eventide Gilead N | 2.38M | 3.59% | 413.90K |
| Vanguard Total Stock Mkt Idx Inv | 2.09M | 3.15% | 2.31K |
| Vanguard US Total Market Shares ETF | 2.07M | 3.11% | 2.12K |
| iShares Russell 2000 ETF | 1.70M | 2.56% | -14.74K |
| T. Rowe Price New Horizons | 1.53M | 2.31% | - |
| US Small-Cap Growth II Equity Comp | 1.45M | 2.18% | 395.64K |
| Eventide Healthcare & Life Sciences I | 1.36M | 2.04% | - |
| SPDR® S&P Biotech ETF | 1.33M | 2.00% | -14.23K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 11, 2024 | Marucci Anthony S | PRESIDENT & CEO | Buy | $308.43K |
| Jun 14, 2024 | Martin Samuel Bates | SVP AND CFO | Sell | $608.31K |
| Jun 14, 2024 | Crowley Elizabeth | SR. VP & CPDO | Sell | $1.05M |
| Jun 07, 2024 | Crowley Elizabeth | SR. VP & CPDO | Sell | $525.87K |
| Jun 07, 2024 | Young Diane C. | SVP, CHIEF MEDICAL OFFICER | Sell | $1.59M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 1 | - |
| 2024 Q2 | - | 12 |
| 2024 Q1 | - | - |
| 2023 Q2 | - | - |
| 2023 Q1 | - | - |
CLDX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools